期刊文献+

阿托伐他汀对慢性心力衰竭大鼠左室重构和功能的影响及可能的机制 被引量:3

The effects of atorvastatin in left ventricular remodeling and dysfunction of rats with chronic heart failure and possible mechanisms
暂未订购
导出
摘要 目的探讨阿托伐他汀对异丙肾上腺素(ISO)诱导的慢性心力衰竭(CHF)大鼠左室重构和心功能的影响以及可能的机制。方法将ISO诱导的CHF大鼠随机分成ISO组与ISO+阿托伐他汀组,同时以正常大鼠为对照组。4周后行心动超声、血流动力学、血清细胞因子检查和心脏标本检测(左室质量/体质量)及RT-PCR 检测心肌基质金属蛋白酶-2(MMP-2)mRNA表达水平。结果 (1)与对照组比较,ISO组左室收缩末期内径(LVESD)、左室舒张末期内径(LVEDD)、左室舒张末压(LVEDP)及左室压力最大下降速率(dp/dtmin)明显升高,左室收缩末压(LVESP)、左室压力最大上升速率(dp/dtmax)及左室短轴缩短率(FS)则明显降低(P<0.01);而ISO+阿托伐他汀组,LVESD、LVEDD、LVEDP、dp/dtmin和LVESP、dp/dtmax及FS值则介于对照组与ISO组之间,且与ISO组比较, LVESD、LVEDD、LVEDP及dp/dtmin明显降低,而LVESP、dp/dtmax及FS则明显升高(P<0.05);左室后壁厚度在 ISO组和ISO+阿托伐他汀组没有明显的不同(P>0.05)。(2)与对照组相比,ISO组和ISO+阿托伐他汀组左室质量/体质量(LVW/BW)明显增大(P<0.01);但与ISO组比较,ISO+阿托伐他汀组LVW/BW降低(P<0.05)。 ISO组MMP-2 mRNA表达水平较对照组明显升高(P<0.01),而ISO+阿托伐他汀组较ISO组降低(P<0.05)。 (3)ISO组大鼠血清肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)水平均比正常对照组显著升高(P<0.01); 与ISO组比较,ISO+阿托伐他汀组血清TNF-α和IL-α水平明显降低(P<0.05)。结论阿托伐他汀通过降低ISO诱导的CHF大鼠细胞因子水平,从而改善左室重构及心脏功能。 Objective To investigate the effects of atorvastatin on left ventricular (LV) remodeling and dysfunction of rats with isoproterenol (ISO)-induced chronic heart failure and possible mechanisms, Methods We measured cardiac conformation ,contractile performance, serum cytokines levels and mRNA expression levels of matrix metalloproteinase-2 (MMP-2) in 15 age-matched normal adult rats and 11 rats with ISO-induced heart failure and 14 rats with ISO-induced heart failure but received atorvastatin treatment. Results (1)LV end diastolic diameter (LVEDD), LV end systolic diameter(LVESD), LV end diastolic pressure(LVEDP) and dp/dtmin in ISO group and ISO + atorvastatin group were significantly larger and LV fractional shortening (FS), LV end systolic pressure (LVESP) and dp/dtmax were significantly less than those of control group, respectively (P 〈 0.01 );in ISO + atorvastatin group, LVEDD, LVESD, LVEDP and dp/dtmin were significantly less and FS, LVESP and dp/dtmax were significantly larger than ISO group (P 〈 0.05);there was no significant difference of LV posterior wall thickness at end diastole between ISO group and ISO + atorvastatin group(P 〉 0.05). (2)The ratios of LV weight to body weight(LVW/BW)in ISO group and ISO + atorvastatin group were significantly higher than that in control group (P 〈 0.01 ),but LVW/BW in ISO + atorvastatin group decreased when compared with ISO group (P 〈 0.05 ) ;mRNA expression of MMP-2 was significantly higher in ISO group than in control group (P 〈 0.01 ) ,while it decreased in ISO + atorvastatin group when compared with ISO group (P 〈 0.05). (3)The serum levels of TNF-α and IL-6 were significantly higher in ISO group than in control group (P 〈 0,01),but the serum levels of TNF-α and IL-6 in ISO + atorvastatin group decreased significantly when compared with ISO group (P 〈 0.05). Conclusions Atorvastatin, administered as soon as possible when ISO induced myocardial necrosis occurs, can greatly improve left ventricular remodeling and dysfunction through decreasing the serum levels of TNF-α and IL-6.
出处 《中国地方病学杂志》 CAS CSCD 北大核心 2006年第2期156-159,共4页 Chinese Jouranl of Endemiology
基金 黑龙江省自然科学基金资助项目(D2004-41)
关键词 他汀类药物 细胞因子类 心力衰竭 充血性 心室复建 心功能 Statin Cytokines Heart failure, congestive Ventricular remodeling Cardiac function
  • 相关文献

参考文献7

  • 1杨继章,杨树民.他汀类药物的非降脂作用及临床应用[J].上海医药,2003,24(10):462-464. 被引量:12
  • 2Teerlink JR,Pfeffer JM,Pfeffer MA.Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats [J].Circ Res,1994,75 (1):105 - 113.
  • 3祝善俊,杨丽霞.细胞因子与心力衰竭病人心肌重塑关系的研究[J].岭南心血管病杂志,2001,7(6):401-402. 被引量:5
  • 4Li YY,Feng YQ,Kadokami T,et al.Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy [J].Proc Natl Acad Sci,2000,97(23):12746-12751.
  • 5Shunji H,Hiroyuki T,Tetsuya S,et al.Fluvastatin,a 3-hydroxy-3-methylgluraryl coenzyme a reductase inhibitou,attenuates left ventricular remodeling and failure after experimental myocardial infarction [J].Circulation,2002,105 (7):868-883.
  • 6Koh KK,Son JW,Ahn JY,et al.Non-lipid effects of statin on hypercholesterolemic patients established to have coronary artery disease who remained hypercholesterolemic while eating a step-Ⅱ diet 1 [J].Coron Artery Dis,2001,12(4) :305-311.
  • 7Haramaki N,Ikeda H.Statins for heart failure:a potential for new treatment[J].Cardiovasc Res,2003,60(2) :217-219.

二级参考文献15

  • 1正宗译.NSAID和他汀类药联用可能有防结肠癌作用[J].中国医学论坛报,1999,25(29):7-7.
  • 2Vitol S, Angelin B, Juliusson G. Simvastafin impairs mitogen-induced proliferation of malignant B - Lymphocytes from humansin vivo and in vitro studies. Lipids, 1997, 32(3) :255.
  • 3Clutterbuck RD, Millar BC, Powles RL, et al. Inhibitory effect of simvastatin on the proliferation of human myeloid leukaemia cells in severe combined immunodeficient (SCID) mice. Br J Haematol, 1998, 102(2):522.
  • 4Arita S, Une S, Ohtsuka S, et al. Prevention of primary islet isogrft nonfunction in mice with pravastatin. Transplantation, 1998, 65(11) :1429.
  • 5Jick H, Zornberg GL, Jick SS, et al. Statin and the risk of demential. Lancet,2000,356 : 1627.
  • 6Treasure EB,Klein JL,WeintraLtb WS,et al. Beneficial effects of cholesterol- lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med, 1995,332(8) :481.
  • 7O' Drisoll G, Green D, Taylor RR. Simvastatin, an HMG - coenzyme A reductase inhibitor, improves endothelial function within 1 month . Circulation, 1997,95 (5) : 1126.
  • 8Negre AP, Vanvliet AK. Inhibition of proliferation of human smooth cells by various HMG - CoA reductase inhibitors; comparison with other human cell types. Biochim Biophys Acta Lipids Metabol, 1997, 1345(3) :259.
  • 9Keidar S, Aviram M, Maor I, et al. Pravastatin inhitits cellular cholesterol synthesis and increases low density lipoprotein receptor activity in macrophages: in ritro and in vivo studies. Br J Chin Pharmacol, 1994, 36(6) :513.
  • 10Aoki I, Aoki N, Kawano K, et al. Platelet - dependent thrombin generation in patients with hyperlipidemia. J Am Coil Cardiol,1997, 30(1) :91.

共引文献15

同被引文献41

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部